Fierce Pharma Biopharma News & Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
Gilead’s Kite shortens Yescarta manufacturing time with FDA nod
Jan 30, 2024 · The manufacturing upgrade comes as Kite works through an important launch for Yescarta as a second-line therapy for large B-cell lymphoma. Last month, the FDA allowed additional patient survival ...
FDA panel says more testing needed to solve Moderna trial halt
Dec 13, 2024 · The halt was triggered by an “imbalance,” the FDA said, in cases of severe lower respiratory tract infections (LRTIs) in children in a phase 1 trial of two Moderna RSV vaccines.
UPDATED: FDA lists all doses of Novo's Wegovy as available, …
Oct 31, 2024 · Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, a similar situation is playing out for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
Lilly's Mounjaro will be in short supply through April, FDA says
Apr 2, 2024 · The company acknowledged that some patients may struggle to fill their prescriptions due to “the unprecedented demand for these medicines,” a Lilly spokesperson recently told Fierce Pharma ...
Lady Gaga 'shines' in 2nd Nurtec ODT ad for Pfizer - Fierce Pharma
Apr 10, 2024 · Her audience, however, greeted the ad with mixed reactions. Top comments on her two Instagram posts include “Less lady pharma more lady gaga” and “Girl you need new management,” each of ...
2024's Fiercest Women in Life Sciences - fiercepharma.com
This year, like so many others, has been a bit of a mixed bag for women, and especially for those seeking positions of power. For the second time in the last decade, a woman—the U.S.’ first ...
Roche burnishes breast cancer portfolio with FDA nod for Itovebi
Oct 10, 2024 · Hyperglycemia is a known problem with Novartis’ Piqray. In the phase 3 SOLAR-1 trial that earned Piqray its second-line approval, grade 3 or 4 hyperglycemia happened in 36.6% of patients on the ...